These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23965526)

  • 1. Dietary modification as adjunct treatment in Ménière's disease: patient willingness and ability to comply.
    Luxford E; Berliner KI; Lee J; Luxford WM
    Otol Neurotol; 2013 Oct; 34(8):1438-43. PubMed ID: 23965526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent dizziness after surgical treatment of vertigo: an exploratory study of prognostic factors.
    Teufert KB; Berliner KI; De la Cruz A
    Otol Neurotol; 2007 Dec; 28(8):1056-62. PubMed ID: 18084816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical indicators useful in predicting response to the medical management of Meniere's disease.
    Devaiah AK; Ator GA
    Laryngoscope; 2000 Nov; 110(11):1861-5. PubMed ID: 11081600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10-year review of endolymphatic sac surgery for intractable meniere disease.
    Hu A; Parnes LS
    J Otolaryngol Head Neck Surg; 2010 Aug; 39(4):415-21. PubMed ID: 20643008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic and diet effect on Menière's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines.
    Santos PM; Hall RA; Snyder JM; Hughes LF; Dobie RA
    Otolaryngol Head Neck Surg; 1993 Oct; 109(4):680-9. PubMed ID: 8233504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of second-echelon treatments for Ménière's disease.
    Basura GJ; Lin GC; Telian SA
    JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):754-61. PubMed ID: 25057891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to letter to the editor concerning: Dietary modification as adjunct treatment in Ménière's disease: patient willingness and ability to comply.
    Luxford WM; Luxford E; Berliner KI
    Otol Neurotol; 2015 Jan; 36(1):198-9. PubMed ID: 24979130
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic management of Meniere's disease: an outcome study.
    Derebery MJ
    Otolaryngol Head Neck Surg; 2000 Feb; 122(2):174-82. PubMed ID: 10652386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
    Shea PF; Richey PA; Wan JY; Stevens SR
    Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Middle ear gentamicin-soaked pledgets in the treatment of Ménière's disease.
    MacKeith SA; Whiteside OJ; Mawby T; Bottrill ID
    Otol Neurotol; 2014 Feb; 35(2):305-9. PubMed ID: 24448291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.
    Brinson GM; Chen DA; Arriaga MA
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):415-21. PubMed ID: 17321870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of endolymphatic mastoid shunt surgery in patients with intractable Ménière's disease.
    Yu MS; Lee KS; Chung JW
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):237-42. PubMed ID: 19643258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endolymphatic sac surgery for Ménière's disease: long-term results after primary and revision surgery.
    Wetmore SJ
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1144-8. PubMed ID: 19015441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summating potential and action potential ratio in Meniere's disease before and after treatment.
    Orchik DJ; Shea JJ; Ge NN
    Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.